Detalles de la búsqueda
1.
Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion.
Blood
; 123(9): 1412-21, 2014 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24357730
2.
A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma.
Oncologist
; 20(6): 617-8, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25986244
3.
Young adult daughters of BRCA1/2 positive mothers: what do they know about hereditary cancer and how much do they worry?
Psychooncology
; 22(9): 2024-31, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23417902
4.
Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma.
J Am Acad Dermatol
; 69(1): 61-5, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23453243
5.
Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts.
Biol Blood Marrow Transplant
; 18(5): 805-12, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22015993
6.
Communication about standard treatment options and clinical trials: can we teach doctors new skills to improve patient outcomes?
Psychooncology
; 21(12): 1265-74, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23208837
7.
Side effects that occurred early in people with multiple sclerosis during the first year of treatment with cladribine tablets: a plain language summary.
Neurodegener Dis Manag
; 12(1): 1-7, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35019731
8.
Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndrome.
Biol Blood Marrow Transplant
; 17(3): 421-8, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20870027
9.
Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 17(8): 1196-204, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21193054
10.
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial.
Breast Cancer Res Treat
; 126(1): 221-6, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21046229
11.
MAGNIMS score predicts long-term clinical disease activity-free status and confirmed disability progression in patients treated with subcutaneous interferon beta-1a.
Mult Scler Relat Disord
; 49: 102790, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33571946
12.
Integrated Lymphopenia Analysis in Younger and Older Patients With Multiple Sclerosis Treated With Cladribine Tablets.
Front Immunol
; 12: 763433, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35003076
13.
Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis.
Mult Scler J Exp Transl Clin
; 7(3): 20552173211024298, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34345436
14.
Prediction of veno-occlusive disease using biomarkers of endothelial injury.
Biol Blood Marrow Transplant
; 16(8): 1180-5, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20184961
15.
Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age.
Biol Blood Marrow Transplant
; 16(6): 792-800, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20074656
16.
No evidence of disease activity status in patients treated with early vs. delayed subcutaneous interferon ß-1a.
Mult Scler Relat Disord
; 39: 101891, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31864098
17.
Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Biol Blood Marrow Transplant
; 15(7): 844-50, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19539216
18.
Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience.
Biol Blood Marrow Transplant
; 15(11): 1447-54, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19822305
19.
Subcutaneous Interferon-ß1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing Surveillance.
Adv Ther
; 35(11): 2041-2053, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30255416
20.
Dyspnea Management of Hospice Patients.
Home Healthc Now
; 33(7): 380-4, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26121510
Resultados
1 -
20
de 20
1
Próxima >
>>